Oct 14 |
Abbott: Challenging Comparables, Unappealing Value Limit The Incentive To Go Long Ahead Of Q3 Event
|
Oct 14 |
Abbott's Q3 Earnings Release Coming Up, EPD Business in Focus
|
Oct 14 |
What to Expect From Badger Meter Stock Ahead of its Q3 Earnings
|
Oct 14 |
Columbus Day: Is Stock Market Open Today?
|
Oct 13 |
Wall Street Breakfast: The Week Ahead
|
Oct 11 |
Abbott advances two pulsed field ablation studies for AFib treatment
|
Oct 11 |
Stocks to watch next week: Netflix, LVMH, ASML, Rio Tinto and Goldman Sachs
|
Oct 11 |
Abbott (ABT) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
|
Oct 11 |
Abbott enrolls pivotal PFA study 4 months ahead of schedule
|
Oct 11 |
Abbott Laboratories' (NYSE:ABT) five-year earnings growth trails the respectable shareholder returns
|